A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

NCT02369796 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to terminate the study because the study did not achieve the primary efficacy objective.

Conditions

Interventions

Sponsor

Takeda